Haifeng F. Cai
Tangshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 07, 2026
Association between perfluoroalkyl and polyfluoroalkyl substance exposure and reproductive lifespan and modifying effect of physical activity
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: March 01, 2026
NCOA4-driven ferritinophagy and GSH reprogramming underlie maslinic acid-induced ferroptosis and autophagy in breast cancer.
Journal: Translational cancer research
Published: January 16, 2026
Intrasystem Repeatability of S-Detect for Breast Ultrasound Classification With Identical Static Images: Single-Center Retrospective Repeatability Study.
Journal: JMIR medical informatics
Published: October 22, 2025
An interpretable 18F-FDG PET/CT-based radiomics model for predicting sub-3cm solitary adrenal metastases in cancer patients.
Journal: Frontiers in oncology
Published: August 24, 2025
Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patients.
Journal: Communications medicine
Published: May 14, 2025
Prediction of solitary ≤3-cm small adrenal metastasis based on 18F-FDG PET/CT using a support vector machine model in lung cancer.
Journal: Oncology letters
Published: May 14, 2025
Identifying small thymomas from other asymptomatic anterior mediastinal nodules based on CT images using logistic regression.
Journal: Frontiers in oncology
Published: March 10, 2025
CECT-based simplified scoring model for differentiating low-risk thymomas from hyper-attenuating thymic cysts: A STARD compliant article.
Journal: Medicine
Published: March 02, 2025
Pan‑cancer analysis of the carcinogenic role of WSB2 in human tumors.
Journal: Molecular medicine reports
Published: January 10, 2025
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory study.
Journal: Breast cancer research : BCR
Published: December 04, 2024
Last Updated: 09/26/2026